Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Pascal Soriot

CTech 24/7

  • “We want to be in every clinic”: The Israeli startup out to change early disease detection
  • Full list of Israeli high-tech layoffs in 2025
  • 1-800 Contacts closes Israeli subsidiary 6over6, cuts 60 jobs
  • Once a $400M prospect, Autotalks sold to Qualcomm for less than $100M
More stories in CTech

Pascal Soriot

3 stories about Pascal Soriot
  • AstraZeneca CEO Pascal Soriot. Photo: Bloomberg

    Once Future CEO Could have Taken Teva on a Different Path

    14.12.17|Lilach Baumer, Golan Hazani, and Orr HirschaugeAstraZeneca CEO Pascal Soriot, which backed out of Teva’s CEO position in July, planned on taking the company towards innovation instead of generic focus

  • Teva CEO Kåre Schultz

    New CEO to Break Teva’s Copaxone Habit

    11.09.17|Sophie Shulman, Dror ReichTroubled drugmaker says new CEO must work to quickly regain its financial credibility

  • AstraZeneca CEO Pascal Soriot

    Soriot's Teva Appointment Unlikely, Says Activist Investor

    06.08.17|Golan HazaniTeva’s board was surprised to learn AstraZeneca's CEO Pascal Soriot will not be joining the company. Teva activist investor Benny Landa called an early report on Teva's negotiations with Mr. Soriot "devastating"

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive